Mangoceuticals Inc. (MGRX) announced that Eli Lilly has made public allegations and filed a lawsuit against the company, claiming that MangoRx improperly copied its weight-loss medications, Zepbound and Mounjaro.
In response, MangoRx categorically denies all claims made by Eli Lilly regarding the sale of compounded tirzepatide. The company believes it has robust arguments to counter Eli Lilly's allegations and is committed to vigorously defending itself in this matter.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.